Laser refractive surgery is a rapidly evolving field in ophthalmology. We carried out a national UK survey to acquire information regarding surgeon demographics, types of excimer laser utilised (phototherapeutic keratectomy (PTK), photorefractive keratectomy (PRK), laser assisted in situ keratomileusis (LASIK), laser epithelial keratomileusis (LASEK)), indications, and the complication rates within the UK by consultant ophthalmologists (accredited independent practitioners from the Royal College of Ophthalmologists (RCO)).
The Postal questionnaires were sent to all 903 ophthalmology consultants registered with the RCO in the UK. The questionnaire was anonymous and single paged to encourage a high response rate (Figures 1 and 2) .
The overall response rate was 49.1% (443 out of 903) which compares with the response rates from US surveys 11.8-18.4%. [4] [5] [6] [7] [8] Five per cent of the respondents had performed excimer therapy in the previous month and all were corneal specialists.
Forty-four percent of the consultants treated patients privately alone whereas 48% treated both National Health Service (NHS) and private cases, and 8% did not respond in this regard.
Twenty-three consultants reported on their refractive practice over the previous month. ) on 3.5% of the patients.
In 57 patients treated with PTK, recurrent erosion syndrome (40.4%) was the most common indication followed by band keratopathy (29.8%), post graft astigmatism (21.1%), and treatment of corneal dystrophy (3.5%). Our study is the first UK national survey of excimer laser use by RCO accredited ophthalmology consultants and provides novel information in the use of excimer laser for both refractive and therapeutic indications.
Consultant Ophthalmologists use of EXCIMER lasers in the UK

Sir, Conjunctival rhabdomyosarcoma presenting as a squamous papilloma
We report the case of an 8-year-old girl who presented clinically with a right conjunctival papilloma. As a precaution, because the lesion continued to grow, a biopsy was performed and showed rhabdomyosarcoma. This is a highly unusual presentation of a rare tumour 
